Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial | American Society of Nephrology
Behandeling van diepe veneuze trombose in het tijdperk van de directe orale anticoagulantia | Tijdschrift voor Cardiologie
XARELTO | Anti-coagulant | Nanotechnology Products | NPD
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March
A) Switching from VKAs to rivaroxaban. (B) Switching from rivaroxaban... | Download Scientific Diagram
Rivaroxaban May Yet Protect After a Hospital Stay: MARINER | tctmd.com
Patient Profile in Labeled and Off-Labeled Dose in RIvaroxaban and... | Download Scientific Diagram
Frontiers | Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Pharmacology
Biomedicines | Free Full-Text | Updates in Anticoagulation Therapy Monitoring | HTML
Frontiers | Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing | Pharmacology
The Significance of Drug–Drug and Drug–Food Interactions of Oral Anticoagulation | AER Journal
PDF) Impact of CYP3A4*1G Polymorphism on plasmatic concentration profile of rivaroxaban (Xarelto (R)) assessed by coagulation assays
Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist | touchCARDIO
References in Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial - The Lancet
Inappropriate Dosing of Direct Oral Anticoagulants in Older Patients with Non-Valvular Atrial Fibrillation: Impact on Plasma Drug Levels - ISTH Congress Abstracts
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants | Journal of the American College of Cardiology
Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation | Circulation: Cardiovascular Interventions
Patient Profile in Labeled and Off-Labeled Dose in RIvaroxaban and... | Download Scientific Diagram
Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update | Gut
Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA Practical Guide - International Journal of Cardiology
Global Prospective Safety Analysis of Rivaroxaban - ScienceDirect
Improved Dosing and Administration of Rivaroxaban when Prescribed by a Cardiologist | touchCARDIO
Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis - European Journal of Internal Medicine
Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations - Journal of Vascular and Interventional ...
Practical guidance for using rivaroxaban in patients with atrial fibri | VHRM
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial - Gastroenterology
